Targeting pancreatic cancer for better treatment options
Selective Targeting of Pancreatic Cancer SPORE
This study is looking at how genes and the environment affect pancreatic cancer to find better treatments, so if you or someone you know is dealing with this tough disease, this research could lead to more effective options in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10977271 on NIH RePORTER |
What this research studies
This research focuses on improving treatment options for pancreatic cancer, a disease known for its high mortality rate and limited therapies. The team is investigating the genetic and environmental factors that contribute to the disease's progression and resistance to current treatments. By analyzing tumor characteristics and the surrounding environment, they aim to identify potential biomarkers and develop more effective therapies. The research involves collaboration among various projects to address the complexities of pancreatic cancer and enhance precision oncology approaches.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic cancer, particularly those with advanced disease or limited treatment options.
Not a fit: Patients with early-stage pancreatic cancer or those who do not have a confirmed diagnosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and improved survival rates for patients with pancreatic cancer.
How similar studies have performed: Previous research has shown promise in targeting pancreatic cancer through genomic analyses and immunotherapy approaches, indicating potential for success in this area.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Yeh, Jen Jen — Univ of North Carolina Chapel Hill
- Study coordinator: Yeh, Jen Jen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.